In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs.
Critically ill patients are easily complicated by cytokine storms, acute respiratory distress …

Discussion Clinical manifestations of Corona virus disease-2019 (COVID-19) have ranged
from asymptomatic/mild symptoms to severe illness and mortality. 1 Most of the mild and …

As of May 6, 2020, nearly 3· 7 million people have been infected and around 260 000
people have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all …

Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a
reduction in lung compliance and capacity. The development of PF is relatively rare, but it …

Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …

With the COVID-19 pandemic having reached tremendous proportions, post-mortem series
are under the limelight to explain many of the peculiar clinical findings. Pathological …

Pulmonary fibrosis (PF) is characterised by several grades of chronic inflammation and
collagen deposition in the interalveolar space and is a hallmark of interstitial lung diseases …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions
worldwide with a high mortality rate due to a lack of definitive treatment. Despite having a …

In December 2019, the first data emerged from Wuhan, China, of a serious acute respiratory
disease caused by a new coronavirus, SARS-CoV-2 (COVID-19). In a short time, the health …